Cross-sectional analyses in three cohorts demonstrated that elevated CSF sTREM2 concentrations in AD patients correlate with tau-mediated neurodegeneration rather than reduced Aβ plaque burden in the A+T− populations [209, 212, 214]. Here, MAPT is linked to Alzheimer disease.